Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Idle

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
Life Sciences|March 1, 1978
Hypotensive response to debrisoquine and hydroxylation phenotypeJ R Idle, A Mahgoub, R Lancaster, et al.
Environmental Health Perspectives|November 1, 1994
Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibilityA K Daly, S Cholerton, M Armstrong, et al.
Biochemical Society Transactions|January 1, 1976
The conjugation of arylacetic acids in the pigeon compared with the henJ R Idle, P Millburn, R T Williams, et al.
Pharmacology & Therapeutics|February 1, 1993
Metabolic polymorphismsA K Daly, S Cholerton, W Gregory, et al.
Biochemical Society Transactions|January 1, 1977
Glutamine conjugation of phenylacetic acid in the ferret [proceedings]P C Hirom, J R Idle, P Millburn, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Cytochrome P450dbl phenotypes in malignant and benign breast diseaseJ E Pontin, H Hamed, I S Fentiman, et al.
Journal of Clinical Periodontology|May 1, 1992
The incidence and severity of nifedipine-induced gingival overgrowthS Barclay, J M Thomason, J R Idle, et al.
Pharmacogenetics|April 1, 1997
Characterization of the 16+9 kb and 30+9 kb CYP2D6 XbaI haplotypesR Løvlie, A K Daly, J R Idle, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
The effect of route of administration and fractionation of dose on the metabolism of ifosfamideM J Lind, H L Roberts, N Thatcher, et al.
Pharmacogenetics|June 1, 1996
CYP2D6 genotypes in cigarette smokers and non-tobacco usersS Cholerton, C Boustead, H Taber, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
Life Sciences|March 1, 1978
Hypotensive response to debrisoquine and hydroxylation phenotypeJ R Idle, A Mahgoub, R Lancaster, et al.
Environmental Health Perspectives|November 1, 1994
Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibilityA K Daly, S Cholerton, M Armstrong, et al.
Biochemical Society Transactions|January 1, 1976
The conjugation of arylacetic acids in the pigeon compared with the henJ R Idle, P Millburn, R T Williams, et al.
Pharmacology & Therapeutics|February 1, 1993
Metabolic polymorphismsA K Daly, S Cholerton, W Gregory, et al.
Biochemical Society Transactions|January 1, 1977
Glutamine conjugation of phenylacetic acid in the ferret [proceedings]P C Hirom, J R Idle, P Millburn, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Cytochrome P450dbl phenotypes in malignant and benign breast diseaseJ E Pontin, H Hamed, I S Fentiman, et al.
Journal of Clinical Periodontology|May 1, 1992
The incidence and severity of nifedipine-induced gingival overgrowthS Barclay, J M Thomason, J R Idle, et al.
Pharmacogenetics|April 1, 1997
Characterization of the 16+9 kb and 30+9 kb CYP2D6 XbaI haplotypesR Løvlie, A K Daly, J R Idle, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
The effect of route of administration and fractionation of dose on the metabolism of ifosfamideM J Lind, H L Roberts, N Thatcher, et al.
Pharmacogenetics|June 1, 1996
CYP2D6 genotypes in cigarette smokers and non-tobacco usersS Cholerton, C Boustead, H Taber, et al.
Pageof 20